Sunil S. Raikar, MD
-
Research Program
-
Email Address
Biography
Sunil S. Raikar, MD, is an assistant professor in the Department of Pediatrics at Emory University School of Medicine. A physician-scientist, Dr. Raikar is a member of both the Cell and Gene Therapy Program and the Leukemia-Lymphoma Program at the Aflac Cancer and Blood Disorder Center at Children’s Healthcare of Atlanta/Emory University.
Education
Dr. Raikar earned his MD from Saint Louis University School of Medicine in Saint Louis, Missouri where he also completed his residency in pediatrics. He completed his post-doctoral training with a fellowship in pediatric hematology/oncology at Emory University School of Medicine in Atlanta, Georgia.
Titles & Roles
-
Assistant Professor, Department of PediatricsEmory University School of Medicine
Professional Memberships
Dr. Raikar is also a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He holds memberships with multiple professional organizations including American Society for Pediatric Hematology and Oncology, Children's Oncology Group, American Society of Hematology and American Society of Gene & Cell Therapy.
Research
The overall goal of Dr Raikar’s research program is to develop novel therapeutics for pediatric blood cancers through (i) development of innovative cellular immunotherapies utilizing chimeric antigen receptors, (ii) production of novel recombinant protein-based therapeutics such as L-asparaginase and (iii) identifying new therapeutic targets in rare leukemias utilizing advanced bioinformatic tools. The specific diseases his laboratory investigates include acute lymphoblastic leukemia, acute myeloid leukemia and mixed phenotype acute leukemia.
Grants
-
Grant Number Title 1K08CA248962-01 Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia 5K08CA248962-02 Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia 5K08CA248962-03 Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia 5K08CA248962-04 Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia 5K08CA248962-05 Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia Title/Journal Authors Publication Date Lab on a chip
T Yu, N Jhita, P Shankles, A Fedanov, N Kramer, SS Raikar, T Sulchek 07/11/2023 Genome medicine
HL Mumme, SS Raikar, SS Bhasin, BE Thomas, T Lawrence, EP Weinzierl, Y Pang, D DeRyckere, C Gawad, DS Wechsler, CC Porter, SM Castellino, DK Graham, M Bhasin 16/10/2023 Nature communications
H Mumme, BE Thomas, SS Bhasin, U Krishnan, B Dwivedi, P Perumalla, D Sarkar, GB Ulukaya, HS Sabnis, SI Park, D DeRyckere, SS Raikar, M Pauly, RJ Summers, SM Castellino, DS Wechsler, CC Porter, DK Graham, M Bhasin 05/10/2023 Scientific reports
SS Bhasin, BE Thomas, RJ Summers, D Sarkar, H Mumme, W Pilcher, M Emam, SS Raikar, SI Park, SM Castellino, DK Graham, MK Bhasin, D DeRyckere 02/08/2023 Molecular therapy oncolytics
SA Becker, BG Petrich, B Yu, KA Knight, HC Brown, SS Raikar, CB Doering, HT Spencer 15/06/2023 Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines.
Biomacromolecules
LA Birnbaum, EC Sullivan, P Do, B Uricoli, SS Raikar, CC Porter, CJ Henry, EC Dreaden 13/03/2023 Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
Nature communications
M Lee, JAG Hamilton, GR Talekar, AJ Ross, L Michael, M Rupji, B Dwivedi, SS Raikar, J Boss, CD Scharer, DK Graham, D DeRyckere, CC Porter, CJ Henry 03/03/2022 Pediatric blood & cancer
S Raghunandan, J Jain, D Saxe, M Pauly, AA Aljudi, RP Ketterling, AB Carter, SS Raikar 01/03/2022 Blood
CR Funk, S Wang, KZ Chen, A Waller, A Sharma, CL Edgar, VA Gupta, S Chandrakasan, JT Zoine, A Fedanov, SS Raikar, JL Koff, CR Flowers, S Coma, JA Pachter, S Ravindranathan, HT Spencer, M Shanmugam, EK Waller 27/01/2022 Allogeneic gamma delta T cells as adoptive cellular therapy for hematologic malignancies.
Exploration of immunology
N Jhita, SS Raikar 01/01/2022 Cancer reports (Hoboken, N.J.)
SS Ganapathi, SS Raikar, SA Yatsenko, M Djokic, A Bukowinski 01/08/2021 Aging cell
JAG Hamilton, MY Lee, R Hunter, RS Ank, JY Story, G Talekar, T Sisroe, DB Ballak, A Fedanov, CC Porter, EZ Eisenmesser, CA Dinarello, SS Raikar, J DeGregori, CJ Henry 01/02/2021 Cytotherapy
JY Story, JT Zoine, RE Burnham, JAG Hamilton, HT Spencer, CB Doering, SS Raikar 01/01/2021 HemaSphere
J Jain, EP Weinzierl, D Saxe, J Bergsagel, J Gotlib, A Reiter, SS Raikar 01/12/2020 Leukemia
MJ Oberley, SS Raikar, GB Wertheim, J Malvar, R Sposto, KR Rabin, JN Punia, AE Seif, VC Cahen, RJ Schore, DC Luca, T Guinipero, WG Woods, MRG O'Gorman, E Orgel 01/07/2020 Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions.
Journal of hematology & oncology
LC Fleischer, HT Spencer, SS Raikar 29/12/2019 Reports (MDPI)
LH Miller, SI Park, D Saxe, G Lew, SS Raikar 01/09/2019 Journal of pediatric hematology/oncology
SS Raikar, J Felker, KN Patel, G Lew, RF Sidonio 01/10/2018 Transfusion
DV Runco, CD Josephson, SS Raikar, KC Goldsmith, G Lew, M Pauly, RM Fasano 01/05/2018 Hurdles Associated with the Translational Use of Genetically Modified Cells.
Current stem cell reports
SS Raikar, HT Spencer 01/03/2018 Blood advances
CT Petersen, M Hassan, AB Morris, J Jeffery, K Lee, N Jagirdar, AD Staton, SS Raikar, HT Spencer, T Sulchek, CR Flowers, EK Waller 13/02/2018 Blood
SS Raikar, SI Park, T Leong, DL Jaye, FG Keller, JT Horan, WG Woods 01/02/2018 Oncoimmunology
SS Raikar, LC Fleischer, R Moot, A Fedanov, NY Paik, KA Knight, CB Doering, HT Spencer 01/01/2018 Molecular therapy oncolytics
R Moot, SS Raikar, L Fleischer, M Querrey, DE Tylawsky, H Nakahara, CB Doering, HT Spencer 01/01/2016